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Fecal sample collection methods 
and time of day impact microbiome 
composition and short chain fatty 
acid concentrations
Jacquelyn Jones1,2*, Stacey N Reinke3, Alishum Ali1,2, Debra J Palmer4,5 & 
Claus T. Christophersen1,2,3,6
Associations between the human gut microbiome and health outcomes continues to be of great 
interest, although fecal sample collection methods which impact microbiome studies are sometimes 
neglected. Here, we expand on previous work in sample optimization, to promote high quality 
microbiome data. To compare fecal sample collection methods, amplicons from the bacterial 16S 
rRNA gene (V4) and fungal (ITS2) region, as well as short chain fatty acid (SCFA) concentrations 
were determined in fecal material over three timepoints. We demonstrated that spot sampling of 
stool results in variable detection of some microbial members, and inconsistent levels of SCFA; 
therefore, sample homogenization prior to subsequent analysis or subsampling is recommended. 
We also identify a trend in microbial and metabolite composition that shifts over two consecutive 
stool collections less than 25 h apart. Lastly, we show significant differences in bacterial composition 
that result from collecting stool samples in OMNIgene·Gut tube (DNA Genotec) or Stool Nucleic Acid 
Collection and Preservation Tube (NORGEN) compared to immediate freezing. To assist with planning 
fecal sample collection and storage procedures for microbiome investigations with multiple analyses, 
we recommend participants to collect the first full bowel movement of the day and freeze the sample 
immediately after collection.
Our understanding of the relationship between the human gut microbiome and host continues to expand from 
explorations which describe inhabitants, to studies which demonstrate the involvement of the microbiome in 
human health and disease and disorders. Some examples include neurological disorders such as  depression1, 
Alzheimer’s  disease2 and Autism Spectrum  Disorder3, as well as inflammatory diseases such as food  allergies4, 
and inflammatory bowel  diseases5. Advancements in microbiome studies have been accelerated by increased 
sequencing  capabilities6, along with sensitive analytical techniques tailored for the quantification of metabolites 
in fecal  material7,8. Short chain fatty acids (SCFA) are metabolites produced exclusively by resident bacteria, 
and are important for proper gut barrier functioning. Therefore, SCFA are also associated with dysbiosis, and 
other inflammatory  disorders5; and investigating the gut microbiome by combining microbial sequencing data 
and metabolomic approaches has been an important step in unraveling links between resident bacteria, SCFA, 
and health  outcomes9–11. However, stool, which is used as proxy for the distal colon microbiome, is a complex 
matrix of endo- and exogenous material containing a heterogeneous distribution of  microorganisms12, which is 
susceptible to changes during and after collection.
Microbiome profiles may be misrepresented due to subsampling of non-homogenized stool as it has previ-
ously been shown that large variations in bacterial abundance detected via qPCR in non-homogenized stool 
samples were significantly reduced after stool  homogenization13. In addition, the effects of sub-sampling stool 
may be further amplified when performing metabolomic analyses, as highly sensitive techniques are  used8,14. 
Lastly, microbiome profiles can also be influenced by sequencing depth, as shown by random subsampling of 
shotgun metagenomic sequence  data15.
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Stool collection by participants may be an undesirable yet necessary aspect of partaking in a microbiome 
study. Providing participants with a clean and simple collection method should increase compliance, but also 
maintain sample integrity. Some commercial stool collection tubes allow for easy collection and short term 
(~ 14 days) ambient temperature storage; however, some of these have been associated with changes in propor-
tions of bacterial  phyla16. A final consideration is the level of inter-individual differences that occur in the fecal 
microbiome over a  week17, and even from day to  day18, meaning that collection periods may need to span a 
number of days, or be collected at a particular time in the day to accurately capture the inherent variability. As 
far as the authors are aware spatial and short-term temporal variability of bacterial and fungal communities has 
never been evaluated together with SCFA composition. To address this gap, this study will assess the effects of 
five fecal sample collection methods, as well as consecutively collected whole stool samples (less than 25 h apart), 
on the variability of the fecal microbiome. The comparisons will be drawn from bacterial and fungal community 
composition as well as SCFA profiling.
Results
Overview of microbiome taxonomy and SCFA concentrations. Stool samples yielded bacterial 
communities (bacteriome) from all individuals and sampling methods, while fungal communities (mycobi-
ome) were successfully sequenced in 53 of 78 samples, but with uneven library size (~ 100×). Overall, the fecal 
bacteriome had a higher number of ASVs than the mycobiome (Supplementary Table 1). Across all individuals 
and collection methods, the most abundant bacterial families were Bacteroidaceae and Lachnospiraceae, which 
made up 38% and 10% of the bacteriome, while the most abundant fungal families were Saccharomycetaceae 
90%, and Phaffomycetaceae 7%. To account for technical bias in library preparation, a single sample from one 
individual was also processed in duplicate. Bacterial α-diversity estimates for this replicate sample were more 
similar than the fungal replicate, while fungal replicates also had low richness, indicating that both the rarity of 
this community, and the library preparation may impact the interpretation of relative abundance of fungal com-
munities (Supplementary Table 1).
Bacterial and fungal mock communities were also sequenced as positive controls, which allowed reads of the 
mock community samples (positive control) to be compared to the known composition of the mock community 
(Supplementary Fig. 1). Still, both mock communities contain a number of species that are not expected to be 
captured in the human fecal microbiome, and therefore, may not be amplified by the selected primers. Of the 
20 bacterial species known to be in the mock community, 18 were correctly detected to family level and 15 to 
genus level, leaving two species of the mock community unidentified. At the level of order, the proportion of 
each ASV in the positive control was compared to the known percentage contribution of the mock community. 
Actinomycetales, Campylobacterales and Rhodobacterales were under represented at 3.5, 3.2, and 4.6 times less 
that what was expected; while Bacillales and Clostridiales were over represented at 3.4 and 4.4 times more than 
expected. Of the 19 fungal species in the mock community 13 were sequenced and correctly resolved to family 
and genus (however, R. irregularis only had 11 reads), leaving six species of the mock community unidentified. 
However, four of these species (Chytriomyces hyalinus, Rhizomucor miehei, Rhizoctonia solani, and Ustilago 
maydis) are not expected to be part of the human microbiome, and were not detected with the ITS2 primers 
developed for use in the human fecal microbiome.
The mycobiome signature of each subject was not as distinct as the bacteriome (Fig. 1). While fungal com-
munities tended to cluster by subject, an analysis by PCoA, shows the mycobiome of individuals one and six 
overlaps. This seems to be driven in both individuals by Saccharomyces dominating the composition by ≥ 99%. 
Further, when a distance based (Euclidian, and Bray–Curtis) ordination β-diversity analysis was conducted on 
abundance data between individuals over the collection period—with all sample types and sample points—sig-
nificant differences in both bacterial and fungal communities were detected (PERMANOVA p < 0.02).
SCFA concentrations were determined from whole stool as well as surface collected aliquots, and overall the 
average molar ratio of acetate, propionate, and butyrate was 78:12:10 respectively. The mean concentrations of 
Figure 1.  Clustering of microbiome communities per individual from all directly frozen stool samples collected 
per individual. Plots show the mycobiome (A) of each individual is less distinct than bacteriome (B). Data was 
CLR transformed and ordination based on Euclidian distances.
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individual or total SCFA in µmol per gram of feces was not significantly different between collection methods; 
and in all subjects, acetic acid was most variable, ranging from an average of 103–697 µmol  g−1.
Comparison of surface aliquots and whole stool sampling methods. To assess the impact of sam-
pling method on a-priori grouping by individual, a hierarchical cluster analysis was performed on bacterial and 
fungal communities (Fig. 2). Bacterial communities from the same subject grouped together, with a SIMPROF 
test identifying significantly different sub clusters for five of six individuals. Fungal communities also clustered 
according to individual, but these groups were less similar than their respective bacterial groups. Furthermore, 
the aliquots from participant six clustered more closely to participant one than to its own respective whole stool 
sample. The mycobiome and bacteriome from the combined aliquot clustered according to individual, however 
did not seem to align consistently with the other aliquots.
To assess the heterogeneity of SCFAs and bacterial diversity within a single stool, the coefficient of variation 
(CV) for these measures was compared across three aliquots from a single stool and three separate stools (col-
lected over 3 days) per individual (Supplementary Table 2). Acetic acid and valeric acid, were found to be as 
variable along a single stool as they were across three bowel movements, whereas propionic was more variable 
across bowel movements. Overall, the SCFA concentrations were more variable across three bowel movements 
than along a single stool except in individuals one and six. Shannon diversity was less variable along a single stool 
(five of six individuals), Chao1 species richness was more variable along a single stool (four of six individuals), 
and Phylogenetic diversity was equally variable along a single stool (three of three individuals). This trend was 
further assessed by integrating SCFA data with bacteriome data through rCCA (distance between features were 
relatively short, indicating the strong agreement between datasets), and the plotted canonical variates show the 
variability between the surface collected samples was still evident in subjects 1, and 6 (Fig. 3).
Within each individual the composition of microorganisms within the aliquots were not identical to each 
other, or to the whole stool from which they were sub sampled. DESEq2 was used to compare differentially 
abundant ASVs between aliquots and whole stool. This method identified 12 bacterial, and 16 fungal features 
with a  log2 fold change greater than |2.5|. Of these, five bacterial and one fungal ASVs were significantly enriched 
in the whole stool compared to aliquots, and one fungal ASV was enriched in stool aliquots compared to whole 
stool (Table 1).
Bacterial community composition is affected by collection methods. Differences in bacterial 
communities due to collection method were visualized using PCoA (Fig. 4). The ordination plots showed a clear 
separation between directly frozen samples (method F) and those collected with either the Norgen (collection 
Figure 2.  Clustering mycobiome (A), and bacteriome (B) from whole stool, aliquot, and combined aliquot 
sampling methods. A SIMPROF test with alpha = 0.05 was used to determine significantly similar sub groupings 
within individuals, with red dashed lines grouping samples which are significantly similar, and solid black likes 
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Figure 3.  Variability of bacterial community and SCFA composition due to stool homogenization methods. 
Datasets where combined using rCCA in the R package  MixOmics61, correlation coefficients were plotted 
in the shared X–Y space. Bacterial ASV counts were CLR transformed, and SCFA concentration were log10 
transformed.
Table 1.  ASVs identified with log2 fold change in gematric mean abundance greater than |2.5| between 
homogenized whole stool and stool aliquots. a Significant enrichment.
ASV Taxa log2 fold change
Bacteria
591 Anaerotruncus massiliensis 6.62
790 Anaerovoracaceae 17.92a
802 Anaerovoracaceae 17.92a
70 Eubacterium sp. 2.89
4 Fecalibacterium prausnitzii − 3.41
27 Fecalibacterium prausnitzii 2.71
405 Fecalibacterium prausnitzii 17.47a
717 Oscillibacter ruminantium 19.52a
461 Rhizobiaceae 18.36a
Fungi
19 Alternaria alternata − 2.9
219 Aspergillus niger 3.9
119 Aureobasidium pullulans 17.2a
8 Cyberlindnera jadinii 3.9
4 Eremothecium sinecaudum − 3.5
41 Hanseniaspora uvarum − 24.1
11 Hanseniaspora uvarum − 8.6
5 Kazachstania barnettii − 22.5
2 Kazachstania servazzii − 21.4a
132 Rhodotorula mucilaginosa 9.1
29 Saccharomyces cerevisiae − 23.5
6 Saccharomyces cerevisiae 4.9
17 Sporopachydermia lactativora 5.0
40 Wickerhamomyces ciferrii 7.3
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method N), or OMNIgene·Gut tubes (collection method O). This separation was confirmed to be significant 
after β-diversity (both Bray–Curtis and Euclidian distances) analysis using PERMANOVA, and stool collected 
with method F was significantly different (p < 0.01 for Bray–Curtis and Euclidian distance) to both those col-
lected with the N or O methods. Furthermore, the N and O method where also significantly different to each 
other (p < 0.01 for Bray–Curtis; and p = 0.04 for Euclidian distance). Relative taxonomic abundance analysis of 
whole stool samples according to collection methods revealed that overall the most abundant families were Bac-
teroidaceae (F 38%, N 43%, O 39%), Ruminococcaceae (F 7%, N 17%, O 33%), and Lachnospiraceae (F 10%, N 
15%, O 10%), with the abundance of Ruminococcaceae significantly increased (ANOVA p < 0.001, FDR = 0.007) 
due to collection using the N and O methods compared to the F method. A number of taxa were also recovered 
differentially between the three collection methods (Supplementary Table 3), including some high-ranking taxa 
(Fig. 5).
Short term changes to Microbiome composition and SCFA concentration. All six participants 
collected two consecutive bowel movements within a 25-h period, with five of the six individuals producing two 
bowel movements within 10 h. The total SCFA concentration (p = 0.04) and acetic acid concentration (p = 0.03) 
were significantly higher in the second stool sample compared to the first using a paired t-test. While not sig-
nificant, butyric acid (p = 0.21) was also higher in the second stool for four of six individuals, while bacterial 
richness (p = 0.45) and diversity estimates (p = 0.95) were lower in the second stool collection for four of six 
individuals (Fig. 6). Four ASVs with significant differential abundance in the first stool compared to the second 
were identified using DESeq2. ASV 137 (Acidaminococcaceae), and 191 (Lachnospiraceae), were enriched in 
the second stool, while ASV 104 (Dialisteraceae), and ASV 300 (Muribaculaceae) were reduced in the second 
stool. Additionally, Lachnospiraceae seemed to show a pattern of increased abundance from the first (8%), to the 
second (15%) stool. Fungal communities from three individuals which were successfully profiled consecutively 
did not show any trend between richness and diversity measures.
Stool form according to the Bristol Stool Form Scale (BSFS) was also recorded during sample processing, 
and most individuals (four of six) did not have uniform stool types collected over the three time points. SCFA 
concentrations clustered in a PCA according to BSFS, and when the SCFA data was integrated with 16S ASV 
data using rCCA to maximise correlation, the resulting correlation coefficients also grouped according to stool 
type (Supplementary Fig. 2).
Discussion
Analysis of the fecal microbiome is now commonly complemented by an additional analysis of microbial metabo-
lites such as SCFA. To ensure these data can be represented together without the impact of spatial and temporal 
variability of the fecal material, collection and storage methods for stool samples must be considered. Our results 
Figure 4.  Principal coordinates analysis of β-diversity showing stool samples collected in frozen (n = 18), 
Norgen (n = 18) and OMNIgene·Gut (n = 18) tube types. Clustering shows directly frozen samples are easily 
distinguished from stool collected in stabilizing liquid. Data shown in (A) was 4th root transformed, using 
Bray–Curtis similarity distance and (B) CLR transformed and Euclidian distance.
6
Vol:.(1234567890)
Scientific Reports |        (2021) 11:13964  | https://doi.org/10.1038/s41598-021-93031-z
www.nature.com/scientificreports/
found sporadic detection of low abundance bacterial and fungal species in unhomogenized stool. Further, SCFA 
concentrations were also shown to vary considerably across a single stool.
The level of variability (CV) in microbial diversity and SCFA concentration across a single stool, was com-
pared per participant to the variability across three separate bowel movements. It was expected that temporal 
shifts in community structure over three timepoints would be larger than replicate sampling from a single stool. 
While Shannon diversity was more variable for five of six individuals among whole stool samples, Richness based 
on Chao1 was more variable along a single stool for four of six individuals. As well, SCFA concentrations were 
more variable within a single stool than across three separate bowel movements for two individuals. When the 
bacterial and SCFA data was integrated using rCCA, the intraindividual variability between the aliquots was also 
evident. Clustering of subsamples from individuals 2, 4, and 5 were very tight, indicating little difference in com-
munity structure due to sampling method. Although, samples from subjects 1, 3, and 6 were less tightly clustered, 
implying community structure changes along the surface of the stool in these individuals that are sensitive to 
sampling method. This demonstrates that for some individuals, heterogeneity of microorganisms and microbial 
metabolites in stool may be as great as that observed over the course of 2 days, which will become apparent if 
samples are collected by sub-sampling a small volume of stool. This is consistent with reports of heterogeneity in 
mucosal  bacteriome19, fecal  microbiome13,20, and metabolite  concentrations8. As fecal material moves through 
the colon, the exterior surface is exposed to the mucus layer secreted by epithelial cells. This mucus (which is a 
niche for commensal microbes) accumulates in fecal material, and has been proposed as a mechanism for the 
patchy recovery of microbial species along the surface of  stool12.
While our results show the surface of the stool may have more variability in richness and diversity, the 
β-diversity of bacterial communities between individuals remained significantly different, indicating that relative 
compositional differences due to subsampling are less pronounced than differences between individuals. This is 
consistent with similar work, where β-diversity (weighted UniFrac) was compared across nine stool subsampling 
locations with no significant differences  observed21. Fungal communities however did not seem to be structured 
according to the individual to the same extent as bacterial communities, but was structured in one of two ways: 
Figure 5.  Bacterial phyla with significantly different abundance due to collection method. Groups identified by 
* are significantly different prior to FDR correction and ** after FDR correction.
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dominated by Saccharomyces cerevisiae (≥ 99%), or by hosting a more even abundance of genera including S. 
cerevisiae, and either Kazachstania servazzii and Cyberlindnera jadinii, or Hanseniapora uvarum and Torulaspora 
delbrueckii. In another study targeting fungi in the gut using the ITS1 region, three main mycobiome types were 
found: either dominated by Candida albicans, or Saccharomyces cerevisiae, or multi species  type22. In the present 
Figure 6.  Bacteriome diversity estimates and short chain fatty acid concentration for two consecutive stool 
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study, Candida spp. were not found at greater than 1% of the total community in any individual. However, Can-
dida apicola was also not identified in the fungal mock community which could indicate an unknown technical 
bias against this group, although presumably not due to primer bias as low abundance was detected and this 
primer set has been used successfully for other Candida  species23.
Metabarcoding based microbiome investigations are inherently biased as the technique is limited by its semi-
targeted design and the compositionality imposed by the NGS technology it uses. This facts is well known in 
the research community and thus it is encouraged to take corrective steps to reduce any distortion of the “true 
composition” of the microbial community by unintentional preferences in the workflow for some taxa over 
 others24. Bias arises at every stage of the microbiome workflow and has recently been recognized as multiplica-
tive through to bioinformatics, although the largest contributors to this bias are upstream steps such as DNA 
extraction and PCR  amplification24,25. The mock communities included in this study indicate that both Bacillus 
sp., and Clostridium sp., who are active members of the human gut microbiome, seemed to be preferentially 
targeted by amplification and sequencing. On the other hand, the proportion of Rhodobacter sphaeroides, and 
Helicobacter pylori were suppressed, and Cutibacterium acnes was not detected. However, suppression of C. 
acnes and R. sphaeroides is less concerning given they are not members of gastrointestinal community. It is also 
important to acknowledge that the sequence data presented here does not represent the actual number of DNA 
molecules recovered from the stool samples; and is limited by the capacity of the sequencing process. Therefore, 
the number of reads per sample, or read depth may impact the calculation of β-diversity indices by inflating the 
between sample diversity of samples with fewer  reads26. Despite the general move in the field towards accepting 
that microbiome is compositional, the question of compositionality being driven by NGS or microbiome versus 
the count origin of microbiome data remains a topic of  discussion27. Other work on the topic of bias and data 
correction states that the sensitivity of a β-diversity measure to sequencing effort can also be impacted by the 
thresholds used to remove rare  species28, the data normalization approach, and the presence of samples with fewer 
than approximately 1000  sequences29. In this work the widely used Bray–Curtis dissimilarity index was used as 
a distance measure to illustrate community differences between subjects and collection methods; this enabled 
us to directly compare our results with prior studies addressing the topic of sample collection. However, this 
distance measure may not always be the most reliable approach for compositional data with the characteristics 
previously  described26.
The microbiome is often scrutinized for small community changes in association with host-related biological 
factors such as diet or disease. These changes in microbial signatures are often detected in less abundant taxa, 
or only within particular groups of bacteria and can vary among individuals. Most bacterial ASVs with large 
differential abundance were found to be enriched in whole stool compared to surface aliquots, and all but one 
Alphaproteobacteria were classified as Clostridia. The Internal regions of stool have previously been shown to 
harbor significantly higher abundances of Firmicutes and Bifidobacteria spp. compared to the external  surface13. 
In this study, the external surface of stool was likely targeted by surface aliquot collections, rather than the 
internal regions of stool, and if the internal regions of stool harbor larger abundances of Firmicutes, this might 
explain some of the differences seen between the surface aliquots and the homogenized whole stool. On the 
other hand, half of all fungi with large differential abundance were found to be reduced in whole stool compared 
to the surface aliquots; and of these all but one Dothideomycetes were classified as Saccharomycetes, indicating 
Saccharomycetes may be a mucosal associated fungus in the gut.
The long-term view of the healthy human gut microbiome seems to show a dynamic community which retains 
prolonged stability, but is punctuated by periods of  disturbance30,31 On a shorter timescale, diet has been shown 
to cause fluctuations in microbial  species32, as well as SCFA  concentrations33. Furthermore, the microbiome shift 
caused by daily food choices is highly personal, meaning the same food will elicit a unique response in each 
 individual34. What microbiome shifts may look like across consecutive stools has not been previously explored. 
While only a small proportion of women defecate more than once a day, defecation frequency is known to be 
higher in  men35, and positively associated with vigorous physical activity, as well as plant based or high fiber 
 diets36. Therefore, the time of day that samples are collected may need to be indicated in sample collection pro-
tocols provided to participants. In this study, all women claimed to regularly defecate more than once a day, and 
the second stool of the day (collected on average 8 h after) had significantly higher total SCFA concentrations, 
which seemed to be driven by significantly higher concentrations of acetic acid. The second stool also tended to 
have higher butyric acid concentrations, lower bacterial richness and lower Shannon diversity index compared to 
the first stool, although these differences were not significant. Similarly, a recent study assessing the microbiome 
and SCFA concentrations at a single timepoint in 441 adults found that lower bacterial diversity was associated 
with higher SCFA  concentrations37. It has been proposed that the gut microbiome has a certain level of volatility 
which may increase during times of  stress38, and the level of temporal variance between the two constitutive stools 
may indicate a normal level of volatility in the microbiome of each individual. Another interesting observation 
was the similar trend in increase in butyrate producing Lachnospiraceae, and increased butyrate concentrations 
in the second bowel movement. The association between bacteria and SCFA concentration seen in this study 
also supports the idea that bacterial metabolites are linked to the circadian  clock39. Each participant collected 
the first bowel movement of the day in the morning, followed by the very next bowel movement; and as each 
woman claimed to regularly defecate at least twice per day, the natural volatility of the microbiome that seems to 
be linked to the circadian clock demonstrates why time of stool sample collection may be particularly important 
in individuals who defecate more than once per day.
Decreasing bacterial richness has also been found to correlate with decreasing stool firmness, or a higher 
Bristol Stool form value, based on fecal samples from 53  women40. As well, the BSFS has also been shown to be 
a good predictor of whole-gut transit time, with high stool form values correlating to longer transit  times35,41,42. 
A more recent study also found when stool form had a Bristol Stool value of less than three it was correlated 
with greater transit times, indicating that stool form can help predict whole-gut or colonic transit  times43. While 
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this study had a small sample size, it was interesting to note that both SCFA and bacterial phylogenetic diver-
sity grouped according to stool form, and when these data were integrated through rCCA this trend was also 
observed. The link between transit time, microbial composition and SCFA concentration has been examined in 
an in-vitro system (Environmental Control System for Intestinal Microbiota). Here, it was shown that reducing 
the transit time from 48 to 96 h caused a significant decrease in Shannon diversity, as well as an increase in total 
SCFA  concentration44, as demonstrated in our study. Quantitative shifts in metabolic analysis between retention 
times also indicated a metabolic shift in the microbial communities. If microbial diversity and SCFA concentra-
tion are linked to transit time, and potentially to stool form as discussed above, assessing stool form at the point 
of sample processing could be a simple way to add valuable information to downstream multivariate analysis, and 
help explain sample clustering. Further, to reduce within-day variability that could potentially distort a long-term 
study, participants could be instructed to collect at a similar time, such as the first bowel movement of the day.
Directly freezing stool samples with no additional solution is considered the gold standard method for storing 
stool, while Norgen and in OMNIgene·Gut tubes offer a convenient method of collecting fecal material from 
remote participants. Regardless of collection method, all whole stool samples were dominated by Bacteroidaceae, 
but the second most abundant family Ruminococcaceae were significantly expanded in samples collected with 
both the O and N methods compared the F method, indicating that the two preservation methods may impact 
fecal microbiomes in a similar way. As expected, bacterial β-diversity was mostly driven by inter-individual 
differences, and this is consistent with previous work where OMNIgene·Gut kits were compared to immedi-
ately frozen stool  samples45. However, unlike  Wang45 where no significant differences in bacterial β-diversity 
between these two methods was observed, our data shows significant differences between the three collection 
methods. The most obvious difference was between the directly frozen samples compared to either of the two 
other preservation methods (collected at room temperature), and this was observed consistently in all three 
bowel movements per participant.
Two additional studies have also compared fecal bacterial communities collected using OMNIgene·Gut kits 
which were frozen prior to processing with samples which were immediately frozen. One study found storage 
methods, contributed to the significant differences between samples based on Bray–Curtis dissimilarity measure, 
and that those collected in OMNIgene·Gut kits had a significant increase in  Proteobacteria46; while another study 
found that samples stored in OMNIgene·Gut tubes resulted in microbiome profiles with decreased Actinobacteria 
and increased Lentisphaerae compared to those that were frozen without  stabilization16,45. Within our study, 
the preservation tubes were kept at room temperature—in accordance with manufacturer’s instructions—and 
at the phyla level Actinobacteria were also reduced in fecal samples collected with both the O and N methods. 
It is more likely then, that the reduction in Actinobacteria is a result of storing in a preservation liquid, rather 
than the storage temperature.
Stool sample collection methods must not sacrifice sample “viability” for convenience, therefore, where 
possible we recommend collecting stool in bulk and freezing immediately. As well, during sample processing 
technicians should take note of the stool form according to BSFS, and homogenize the entire sample prior to 
subsampling for analysis. This method eliminates any subsampling bias due to heterogenous distribution of 
microbes in stool, and provides enough material for multiple assays. Additionally, because this method is less 
hands-on for participants, it may increase compliance if multiple collections are required. For studies where it is 
not possible to store a large quantity of bulk stool or where frozen transportation of stool is not viable, commercial 
preservation tubes may be an attractive alternative. In this circumstance it is recommended to only use a single 
tube type and insure a standard protocol. Furthermore, if OMNIgene·Gut or Norgen collection kits are used, 
researchers should be cautious in interpreting the reduced abundance of Firmicutes and Actinobacteria. Lastly, 
collection protocols should consider that some individuals can regularly have more than one bowel movement 
per day, and those participants should be instructed, where practical, to collect stool at a similar time.
Methods
Study design. Six healthy female volunteers, aged 25–40 years, who had not taken antibiotics in the last 
3 months or probiotics in the last month prior to recruitment into this study provided fecal samples with written 
informed consent. The study protocol was approved by the Human Research Ethics Committee (HRE2018-
0791) from Curtin University, Western Australia, and methods were performed in accordance with the relevant 
guidelines and regulations. Each participant collected three fecal samples at two time points using the provided 
fecal sample collection kit. All stools were collected at the participants home and frozen immediately (− 20 °C) 
in a portable freezer. Collection at the first time point (collection 1) required collecting one complete bowel 
movement, and from this stool collecting three small aliquots in the provided collection tubes. At the second 
time point, two consecutive bowel movements were collected individually (collection 2 and collection 3), with 
collection 2 preceding collection 3 (Fig. 7). Once the collection was complete, the freezer was transported to 
Curtin University and the stool was transferred to a − 80 °C freezer upon arrival.
Sample preparation. All stool samples were thawed at 4 °C, and transferred on ice to a EuroClone Biologi-
cal safety cabinet to limit potential contamination. To assess variability between aliquots collected at home, each 
of the small aliquots were individually homogenized for 30 s with a sterile plastic scoop, and stool (0.25 g) was 
collected into separate tubes for each of two downstream analyses (metabarcoding, and SCFA quantification). 
The remaining stool from the initial three aliquots was combined and manually homogenized together for 30 s 
with a sterile plastic scoop, and collected again for two separate analyses. All samples were immediately frozen to 
− 80 °C. Prior to preparation, whole stool samples were ranked on the Bristol Stool form chart. To assess collec-
tion methods, from each unhomogenized stool, feces were collected into one OMNIgene·Gut tube (DNA Geno-
tec) (collection method O) and one Stool Nucleic Acid Collection and preservation Tube (NORGEN) (collection 
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method N), and were stored at room temperature for 12 days. The remaining stool from each sample was indi-
vidually homogenized while within the plastic collection bag for 1 min, and then subsequent aliquots of stool 
(0.25 g) were collected for each of the three analyses and immediately frozen to − 80 °C (collection method F).
Short chain fatty acid quantification. Homogenized fecal material (0.50 ± 0.05  g) was transported 
on dry ice to the Science Analytical Facility at Edith Cowan University, Western Australia. Here SCFA were 
extracted and quantified as previously  described47. Briefly, an aqueous stock solution of standards containing 
acetic, propionic, iso-butyric, butyric, iso-valeric, valeric, and hexanoic acids was diluted to four levels, and used 
for analysis. SCFA were extracted using a solution of hydrochloric acid, methanol, ultrapure water, and 2-ethyl 
butyric acid which was used as an internal standard. The mixture was vortexed for 1 min, and then incubated at 
4 °C for 1 h, and then vortexed a second time for 1 min. Finally, the solution was Centrifuge at 12000 rpm at 4 °C 
for 20 min, and the supernatant retained and stored at 4 °C for no more than 48 h prior to analysis on Thermo 
Scientific GC–MS (ISQ) using a Thermo Scientific TG-Wax column (30 m × 0.25 mm × 0.25 µm), and a seven-
point calibration. A sample volume of 1.0 µL was injected with an inlet temperature of 220 °C, using Helium 
carrier gas (1.0 mL/min). The total run time was 18 min.
Fecal DNA extraction. Immediately prior to DNA extraction, frozen stool samples were thawed on ice, 
and stool samples stored in preservation tubes were shaken by hand for 10  s. DNA was extracted by using 
QIAamp Power Fecal DNA kit (QIAGEN, Hilden, Germany) using QIAamp Power Fecal DNA IRT protocol for 
QIAcube (QIAGEN), as well as OMNIgene·Gut microbial DNA purification protocol using QIAGEN QIAamp 
PowerFecal DNA kit, both according to the manufacturer’s instructions with one modification at step 3 of the 
IRT protocol, tubes were vortexed for 20 s to incorporate beads and stool prior to heating. Extraction controls 
were also processed following the same protocol as frozen stool samples.
Bacterial and fungal library preparation and sequencing. The V4 region of bacterial DNA and mock 
communities (ATCC MSA-1002) were targeted and amplified using 16S primers  515F48 and  806R49, each with 
a 6–8 bp unique barcode. The PCR reactions contained of 1 × PCR buffer (Applied Biosystems), 2 mM  MgCl2 
(Applied Biosystems), 0.25 nM dNTP (Bioline), 0.4 mg/mL BSA (Thermo Fisher Scientific) 0.4 μM primer (Inte-
grated DNA Technologies), 0.12 × SYBER, and 2U AmpliTaq Gold™ DNA polymerase (Thermo Fisher Scien-
tific). Reactions contained 2 μL of template DNA which was previously screened and optimized for efficiency 
by  qPCR50, and had a final volume of 25 μL. Fungal DNA and mock  communities51 were amplified using ITS2 
primers FSeq and  RSeq23. PCR reactions were the same as for bacterial amplification except 3 μL of template 
DNA was added to each reaction.
The reactions for both bacterial and fungal amplicons were performed on StepOnePlus Real-Time PCR 
system (Applied Biosystems), and under the following conditions for bacterial amplicons: denaturing at 94 °C 
Figure 7.  Sample collection by participants at home (top panel), and subsequent sample processing in 
laboratory (bottom panel). The first bowel movement of the day was obtained for collection 1 and 2, and the 
very next bowel movement after collection 2 was obtained for collection 3.
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for 3 min, followed by 30 cycles of 94 °C for 40 s, annealing at 53 °C for 40 s, and extension at 72 °C for 60 s. The 
cycling program for fungi was as follows: denaturing at 94 °C for 3 min, followed by 35 cycles of 94 °C for 40 s, 
55 °C for 40 s, 72 °C for 80 s. Both amplicons underwent a final extension at 72 °C for 10 min. Individual bacte-
rial and fungal libraries were prepared by blending together in equimolar concentrations. Illumina compatible 
adaptors were ligated to the DNA fragments (Lucigen, Middelton, WI, USA), and the resulting amplicons were 
size selected using Pippin Prep (Sage Science). The QIAquick PCR purification column clean up kit (Qiagen, 
Germantown, MD), was used to purify the DNA library before sequencing, which was performed at Curtin 
University, Western Australia, using the Illumina MiSeq platform and V2 500 cycle kit (Illumina, San Diego, 
CA, USA) with 2 × 250 bp paired-end read lengths.
Deconvolution. Unique molecular barcodes were used to demultiplex reads with no mismatches allowed. 
 Cutadapt52 was used to remove primers, and the remaining reads were quality filtered, trimmed, and merged 
using  DADA253. Reads with ambiguous bases, or with more than two expected errors were discarded. Amplicon 
sequence variants (ASVs) were inferred from the reads using the pseudo-pooled method, and merged with a 
minimum overlap of 60 bp allowing for one mismatch (16S V4), and 30 bp with no mismatches (ITS2). Ampli-
cons were retained at a minimum length of 150, and 251, base pairs for ITS2, and 16S V4, datasets respectively. 
Chimera errors were also removed with DADA2 using the default method. Classification for 16S sequence vari-
ants was performed using the Genome Taxonomy reference database (release 95) formatted for use with DADA2 
(https:// zenodo. org/ record/ 39513 83#. X7Hs4 9sRVTY), while the UNITE general FASTA release for fungi Ver-
sion 18.11.201854 was used for ITS2 sequence classification, each with a minimum of 50% bootstrapping. Con-
tamination was removed from all sequences with one run of the function remove.count in  microDecon55. Any 
ASVs with unassigned phylum, or with a prevalence less than 1 in 5% of samples were filtered out, as were fungal 
samples with less than 1000 reads.
Statistical analysis. Sequence counts were used to determine richness and α-diversity indices (Chao1, 
Shannon, and Faith’s phylogenetic diversity (PD)) for bacterial microbiomes as applied in the “Phyloseq” 
 package56 run in R studio with R version 3.6.357. Correlation between library size and diversity estimate were 
tested for, and α-diversity measures with significant Pearson correlation (p < 0.01) to reads per sample were 
rarefied to lowest sample depth prior to calculation for those α-diversity measures (Chao1 and Faith’s PD). 
β-Diversity was compared between collection methods with PERMANOVA in PRIMER-e  v758 and visualized 
using PCoA using Euclidian distances of center log ratio (CLR) transformed data, as well as Bray–Curtis simi-
larity calculated from 4th root transformed proportions of counts. SCFA concentration data were  log10 trans-
formed, and normality assumed using the Shapiro–Wilk test prior to paired t-test.
To evaluate differentially abundant taxa between homogenization method (aliquots and whole stool), the 
effect size estimate as a log2 fold change was calculated in DESeq2 statistical  package59 with a Benjamini–Hoch-
burg adjustment for multiple testing, and a design controlling for subject. Statistical differences between 
taxa abundance and community diversity due to collection methods were further tested using ANOVA in 
 MicrobiomeAnalyst60 after CLR transformation. Lastly, regularized canonical correlation analysis (integrated 
to maximize correlation between latent variables) was used to integrate SCFA and bacteriome data, both in 
 MixOmics61.
Data availability
ASV tables, metadata and sequences reads are available in the figshare repository https:// doi. org/ 10. 6084/ m9. 
figsh are. 13670 689.
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